These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2479784)

  • 1. [The effects of etretinate and anticancer drugs on the cell line of a squamous cell carcinoma of human skin (HSC-1)].
    Tokuhashi K
    Nihon Hifuka Gakkai Zasshi; 1989 May; 99(6):673-82. PubMed ID: 2479784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
    Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T
    Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis-inducing activity of cisplatin (CDDP) against human hepatoma and oral squamous cell carcinoma cell lines.
    Okamura M; Hashimoto K; Shimada J; Sakagami H
    Anticancer Res; 2004; 24(2B):655-61. PubMed ID: 15161008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro combined effects of pirarubicin (THP) and various antitumor drugs on human tumor cell lines].
    Nagasawa M; Ishii S; Kariya Y; Itoh O; Yamamoto H; Kawaharajo K; Takeuchi T
    Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 1):633-8. PubMed ID: 2108612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonistic interplay between antimitotic and G1-S arresting agents observed in experimental combination therapy.
    Johnson KR; Young KK; Fan W
    Clin Cancer Res; 1999 Sep; 5(9):2559-65. PubMed ID: 10499633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined antiproliferative activity of 5-fluorouracil and mitomycin-C against primary human ovarian tumors and cell lines in a clonogenic assay.
    Higashihara J; Berens ME; Collins LA; Homesley HD; Welander CE
    Gynecol Oncol; 1993 Feb; 48(2):171-9. PubMed ID: 8428687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment with 5-FU enhances cisplatin cytotoxicity in head and neck squamous cell carcinoma cells.
    Ijichi K; Adachi M; Hasegawa Y; Ogawa T; Nakamura H; Kudoh A; Yasui Y; Murakami S; Ishizaki K
    Cancer Chemother Pharmacol; 2008 Oct; 62(5):745-52. PubMed ID: 18075740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of cell death induction by cisplatin and 5-FU in human oral squamous and hepatocellular carcinoma cell lines.
    Okamura M; Shimada J; Sakagami H
    Anticancer Res; 2008; 28(1A):253-9. PubMed ID: 18383853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemotherapy of carcinoma of the prostate and testis: experimental study in vivo and in vitro].
    Okada K; Kanamaru H; Yoshiki T; Hashimura T; Nishimura K; Hida S; Nishio Y; Oishi K; Yoshida O; Yamauchi T
    Hinyokika Kiyo; 1988 Nov; 34(11):1911-6. PubMed ID: 2468265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Etretinate and 5-fluorouracil in intra-anal Bowen's disease].
    Schmidt KU; Wiskemann A; Mensing H
    Hautarzt; 1986 May; 37(5):278-80. PubMed ID: 3733447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of apoptosis by flavopiridol in mitomycin-C-treated gastric and breast cancer cells.
    Schwartz GK; Farsi K; Maslak P; Kelsen DP; Spriggs D
    Clin Cancer Res; 1997 Sep; 3(9):1467-72. PubMed ID: 9815832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of interferon-beta in combination with 5-fluorouracil on the growth of esophageal cancer cells in vitro.
    Tsunoo H; Komura S; Ohishi N; Akiyama S; Kasai Y; Ito K; Nakao A; Yagi K
    Anticancer Res; 2001; 21(5):3301-6. PubMed ID: 11848487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Flow cytometric analysis of effects of chemohormonal agents on the cell cycle distribution of MCF-7 cells].
    Suzuki M
    Nihon Geka Gakkai Zasshi; 1992 Jan; 93(1):71-80. PubMed ID: 1549098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of 5-fluouracil combined with sulfasalazine on human pancreatic carcinoma cell line BxPC-3 proliferation and apoptosis in vitro.
    Huang Z; Guo KJ; Guo RX; He SG
    Hepatobiliary Pancreat Dis Int; 2007 Jun; 6(3):312-20. PubMed ID: 17548258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chemotherapy of renal cell carcinoma: experimental study and clinical effect].
    Kanda H; Matsuura T; Akiyama T; Kurita T
    Hinyokika Kiyo; 1988 Nov; 34(11):1879-84. PubMed ID: 3242362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Langerhans cells in benign, premalignant and malignant skin lesions of renal transplant recipients and the effect of retinoid therapy.
    Gibson GE; O'Grady A; Kay EW; Leader M; Murphy GM
    J Eur Acad Dermatol Venereol; 1998 Mar; 10(2):130-6. PubMed ID: 9553909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of cell death by combination treatment with cisplatin and 5-fluorouracil in a human oral squamous cell carcinoma cell line.
    Okamura M; Kobayashi M; Suzuki F; Shimada J; Sakagami H
    Anticancer Res; 2007; 27(5A):3331-7. PubMed ID: 17970078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inhibitory effects of aromatic retinoic acid analog, administered alone or in combination with mitomycin C, on the in vitro growth of rat bladder carcinoma cells].
    Fujita J; Yoshida O
    Hinyokika Kiyo; 1984 Nov; 30(11):1627-31. PubMed ID: 6241424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor enhancement of HSC-1 human cutaneous squamous carcinoma cell adhesion and migration on type I collagen involves selective up-regulation of alpha 2 beta 1 integrin expression.
    Fujii K; Dousaka-Nakajima N; Imamura S
    Exp Cell Res; 1995 Jan; 216(1):261-72. PubMed ID: 7529189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro schedule-dependent interaction between oxaliplatin and 5-fluorouracil in human gastric cancer cell lines.
    Qin B; Tanaka R; Shibata Y; Arita S; Ariyama H; Kusaba H; Baba E; Harada M; Nakano S
    Anticancer Drugs; 2006 Apr; 17(4):445-53. PubMed ID: 16550003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.